The regulation of pharmaceuticals and medical devices - fields of rapid technological growth and innovation - is a topic of legal, economic, and policy significance. The study of regulation encompasses an exploration of such direct controls as governmental legislation and agency directives and indirect controls like products liability litigation, insurance, intellectual property, and antitrust regimes. The students study how technological advances in the pharmaceutical and medical device industry challenge and demand redefinition of the institutional relationships between agencies and courts, and of the mechanisms of supervision and control provided by the market, government, and common law litigation.

Duration: 29 June  - 9 July 2020

Online Course via ZOOM

Monday, 29 June 2020: 15:00-17:30
Tuesday, 30 June 2020: 15:00-17:30
Wednesday, 1 July 2020: 15:00-17:30
Thursday, 2 July 2020: 15:00-17:30

Monday, 6 July 2020: 15:00-17:30
Tuesday, 7 July 2020: 15:00-17:30
Wednesday, 8 July 2020: 15:00-17:30
Thursday, 9 July 2020: 15:00-17:30

Solid understanding of business and economics on the BA level.

Completion of an introductory course in law (BA) would be helpful.
Health Economics (Gesundheitsökonomie, 27707)
Advanced Public Economics: Behavioral Models and Applications (43497)

Final grades will be determined by class participation (25%), one in-class presentation (25%), and 24-hour take-home final examination (50%).  While the class will be taught remotely using Zoom, it will be interactive with class participation by individuals and in small groups, using break-out rooms.  It is therefore imperative for you to be present and actively participate during the synchronous Zoom meeting classes.

Course Information

• Course directory
• Syllabus: will be available on ADAM
• Reading Material: will be available on ADAM